Evidence map›Paper›PMID 27090199›Full record

ArticleMagnetic resonance in medicine2017

A biomarker-responsive T

Iman Daryaei, Edward A Randtke, Mark D Pagel

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Magnetic resonance in medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Probing nitric oxide signaling using molecular MRI.Free radical biology & medicine · 2022
    Review
  2. Article
  3. Molecular fMRI of neurochemical signaling.Journal of neuroscience methods · 2021
    Review
  4. Article
  5. Triazoles as TChemistry (Weinheim an der Bergstrasse, Germany) · 2018
    Article
  6. Lanthanide-Based TAngewandte Chemie (International ed. in English) · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Iman DaryaeiDepartment of Chemistry and Biochemistry, University of Arizona.
Edward A RandtkeDepartment of Medical Imaging, University of Arizona.
Mark D PagelDepartment of Chemistry and Biochemistry, University of Arizona.

Funding

SPORE in Gastrointestinal CancerP50CA095060 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 2002 to 2012
$25.3M
Detection of in vivo enzyme activities with CEST MRIR01CA169774 · NCI · UNIVERSITY OF ARIZONA · PI CARDENAS-RODRIGUEZ, JULIO · 2012 to 2016
$2.5M
NCI NIH HHS P50 CA095060NCI NIH HHS R01 CA169774
6 · The paper itself

Abstract

purposeThis study investigated a fundamentally new type of responsive MRI contrast agent for molecular imaging that alters T

methodsThe contrast agent Tm-DO3A-oAA was treated with nitric oxide (NO) and O

resultsThe reaction of Tm-DO3A-oAA with NO and O

conclusionsT

Indexed as

AnilidesContrast MediaHeterocyclic Compounds, 1-RingHydrogen-Ion ConcentrationMagnetic Resonance ImagingMolecular ImagingMolecular ProbesMolecular Probe TechniquesNitric OxideOxygenTechnetiumTechnetium CompoundsTemperature1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acidAnilidesContrast MediaHeterocyclic Compounds, 1-RingMolecular ProbesNitric OxideOxygenTechnetiumTechnetium Compoundschemical exchange: molecular imagingnitric oxideresponsive agentT2ex MRI

Identifiers

PMID27090199
PMCPMC5071101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.